Novo Nordisk invests $2.3 billion in Danish production facility
COPENHAGEN (Reuters) -Danish drugmaker Novo Nordisk will invest 15.9 billion Danish crowns ($2.29 billion) to expand a production facility in
2023-06-12 14:15
Novartis Agrees to Buy Chinook for Up to $3.5 Billion
Novartis AG agreed to buy Chinook Therapeutics Inc. for as much as $3.5 billion to add two promising
2023-06-12 13:52
Novartis’s Sandoz Sees Pipeline Adding $3 Billion Sales by 2028
Novartis AG’s generic-drug unit Sandoz could add $3 billion in sales over the next five years from its
2023-06-08 13:48
Novo Nordisk in talks buy controlling stake in Biocorp
Danish drug developer Novo Nordisk said on Monday it had started talks to buy a controlling stake in
2023-06-05 14:30
Powerball lottery winner faces lawsuit alleging ticket theft
Edwin Castro won the jackpot last November - but Jose Rivera claims he is the rightful winner.
2023-05-27 12:25
A Weight Loss Startup Touting Mindfulness, Noom Is Now Prescribing Drugs
Noom Inc., a startup that for years has touted a psychological path to weight loss, is now ready
2023-05-24 23:52
Canada's BMO, Scotiabank report lower income on higher provisions
Bank of Montreal and Bank of Nova Scotia on Wednesday reported lower adjusted earnings at home as the
2023-05-24 19:22
China's Lenovo revenue falls for third consecutive quarter as PC demand slumps
By Josh Ye HONG KONG China's Lenovo Group Ltd on Wednesday reported a 24% fall in revenue for
2023-05-24 12:46
Indian banks start exchanging withdrawn 2,000-rupee notes
The 2,000-rupee notes have been withdrawn, sparking concerns and confusion.
2023-05-23 14:57
G7 Summit: Africa seeks new role as nations eye its resources
As wealthy nations compete, Africa wants to keep more of the benefits from its natural resources.
2023-05-20 07:53
Ghana IMF loan: Will $3bn solve the economic crisis?
Ghanaians are desperate for help but the intervention may not deal with problems in the long term.
2023-05-18 18:20
Drugmakers Eye $23 Billion Biotech Argenx Ahead of Key Data
European biotech firm Argenx SE is scheduled to release key drug trial data this summer. Deal-hungry Big Pharma
2023-05-17 16:20